Group 1: Market Overview - The global medical endoscope market is projected to reach $26.6 billion by 2024, with a CAGR of approximately 6.24% from 2017 to 2024 [1] - The United States is the largest market for medical endoscopes, followed by the European Union and China, with China expected to become the second-largest market and achieve the highest growth rate in the coming years [1] - The demand for single-use endoscopes is increasing due to their ability to significantly reduce infection risks, especially in fields with high infection control requirements such as urology, respiratory, and digestive departments [1] Group 2: Company Developments - OFILM has successfully overcome core technical challenges related to single-use endoscopes by 2025, achieving key performance breakthroughs and breaking international monopolies with high performance and cost advantages [2] - The company's endoscope products feature significant advantages such as miniaturization, stable modulation transfer function (MTF), high clarity, lightweight, waterproof, large depth of field, ultra-wide angle, and ultra-micro distance [2] - OFILM employs "integrated glue injection technology" and "high-precision wire bonding technology" to enhance the sealing of camera modules and stability of circuits, reducing signal transmission delay by 30% and achieving industry-leading imaging clarity [2] Group 3: Production and Future Plans - OFILM's urological system endoscope modules achieved mass production in April this year, with plans for large-scale production of digestive and respiratory system endoscope modules in the second half of the year [3] - The company aims to become the first Chinese manufacturer to supply a full range of endoscope modules globally, with a phased implementation plan for various types of endoscopes [3] - As the global healthcare industry continues to develop, single-use endoscopes are expected to find applications in more fields, indicating a broad market outlook [3]